相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Insights into the pharmacological relevance of lysophospholipid receptors
Tetsuji Mutoh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Special Issue: Guide to Receptors and Channels, 5th Edition Abstracts
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Engagement of S1P1-degradative mechanisms leads to vascular leak in mice
Myat Lin Oo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The Selective Sphingosine 1-Phosphate Receptor 1 Agonist Ponesimod Protects against Lymphocyte-Mediated Tissue Inflammation
Luca Piali et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Heterogeneity of CD4+ memory T cells: Functional modules for tailored immunity
Federica Sallusto et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules
David Marsolais et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Sphingosine-1-phosphate receptor type-1 agonism impairs blood dendritic cell chemotaxis and skin dendritic cell migration to lymph nodes under inflammatory conditions
Gerald Gollmann et al.
INTERNATIONAL IMMUNOLOGY (2008)
Full Pharmacological Efficacy of a Novel S1P1 Agonist That Does Not Require S1P-Like Headgroup Interactions
Pedro J. Gonzalez-Cabrera et al.
MOLECULAR PHARMACOLOGY (2008)
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
M. Mehling et al.
NEUROLOGY (2008)
FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis
Balazs Balatoni et al.
BRAIN RESEARCH BULLETIN (2007)
Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors
Florian Mullershausen et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology
Volker Brinkmann
PHARMACOLOGY & THERAPEUTICS (2007)
Sphingosine-1-phosphate signaling in the cardiovascular system
Stephan L. M. Peters et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis
Thomas Baumruker et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model
Shifeng Pan et al.
CHEMISTRY & BIOLOGY (2006)
The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel IKACh
L Koyrakh et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes
M Forrest et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Transactivation of sphingosine-1-phosphate receptors by FcεRI triggering is required for normal mast cell degranulation and chemotaxis
PS Jolly et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate
MG Sanna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
M Matloubian et al.
NATURE (2004)
Human eosinophil chemotaxis and selective in vivo recruitment by sphinglosine 1-phosphate
F Roviezzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Sphingosine-1-phosphate: An enigmatic signalling lipid
S Spiegel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Amelioration of experimental autoimmune encephalomyelitis in lewis rats by FTY720 treatment
M Fujino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
V Brinkmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
